Global Preterm Labor Treatment Market Size, Status and Forecast 2020-2026

SKU ID :QYR-14566216 | Published Date: 21-Feb-2020 | No. of pages: 96
Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Preterm Labor Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Preterm Labor Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Tocolytic Drugs 1.4.3 Beta – Mimetic 1.4.4 Calcium Channel Blockers 1.4.5 NSAIDS 1.4.6 Corticosteroids 1.4.7 Magnesium Sulphate 1.4.8 Antibiotics 1.5 Market by Application 1.5.1 Global Preterm Labor Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Pediatric and Neonatal Clinics 1.5.4 Nursing Homes 1.5.5 Pharmacy 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Preterm Labor Treatment Market Perspective (2015-2026) 2.2 Preterm Labor Treatment Growth Trends by Regions 2.2.1 Preterm Labor Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Preterm Labor Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Preterm Labor Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Preterm Labor Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Preterm Labor Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Preterm Labor Treatment Players by Market Size 3.1.1 Global Top Preterm Labor Treatment Players by Revenue (2015-2020) 3.1.2 Global Preterm Labor Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Preterm Labor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Preterm Labor Treatment Market Concentration Ratio 3.2.1 Global Preterm Labor Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Preterm Labor Treatment Revenue in 2019 3.3 Preterm Labor Treatment Key Players Head office and Area Served 3.4 Key Players Preterm Labor Treatment Product Solution and Service 3.5 Date of Enter into Preterm Labor Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Preterm Labor Treatment Historic Market Size by Type (2015-2020) 4.2 Global Preterm Labor Treatment Forecasted Market Size by Type (2021-2026) 5 Preterm Labor Treatment Breakdown Data by Application (2015-2026) 5.1 Global Preterm Labor Treatment Market Size by Application (2015-2020) 5.2 Global Preterm Labor Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Preterm Labor Treatment Market Size (2015-2020) 6.2 Preterm Labor Treatment Key Players in North America (2019-2020) 6.3 North America Preterm Labor Treatment Market Size by Type (2015-2020) 6.4 North America Preterm Labor Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Preterm Labor Treatment Market Size (2015-2020) 7.2 Preterm Labor Treatment Key Players in Europe (2019-2020) 7.3 Europe Preterm Labor Treatment Market Size by Type (2015-2020) 7.4 Europe Preterm Labor Treatment Market Size by Application (2015-2020) 8 China 8.1 China Preterm Labor Treatment Market Size (2015-2020) 8.2 Preterm Labor Treatment Key Players in China (2019-2020) 8.3 China Preterm Labor Treatment Market Size by Type (2015-2020) 8.4 China Preterm Labor Treatment Market Size by Application (2015-2020) 9 Japan 9.1 Japan Preterm Labor Treatment Market Size (2015-2020) 9.2 Preterm Labor Treatment Key Players in Japan (2019-2020) 9.3 Japan Preterm Labor Treatment Market Size by Type (2015-2020) 9.4 Japan Preterm Labor Treatment Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Preterm Labor Treatment Market Size (2015-2020) 10.2 Preterm Labor Treatment Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Preterm Labor Treatment Market Size by Type (2015-2020) 10.4 Southeast Asia Preterm Labor Treatment Market Size by Application (2015-2020) 11 India 11.1 India Preterm Labor Treatment Market Size (2015-2020) 11.2 Preterm Labor Treatment Key Players in India (2019-2020) 11.3 India Preterm Labor Treatment Market Size by Type (2015-2020) 11.4 India Preterm Labor Treatment Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Preterm Labor Treatment Market Size (2015-2020) 12.2 Preterm Labor Treatment Key Players in Central & South America (2019-2020) 12.3 Central & South America Preterm Labor Treatment Market Size by Type (2015-2020) 12.4 Central & South America Preterm Labor Treatment Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview and Its Total Revenue 13.1.3 Pfizer Preterm Labor Treatment Introduction 13.1.4 Pfizer Revenue in Preterm Labor Treatment Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Novartis 13.2.1 Novartis Company Details 13.2.2 Novartis Business Overview and Its Total Revenue 13.2.3 Novartis Preterm Labor Treatment Introduction 13.2.4 Novartis Revenue in Preterm Labor Treatment Business (2015-2020) 13.2.5 Novartis Recent Development 13.3 Merck 13.3.1 Merck Company Details 13.3.2 Merck Business Overview and Its Total Revenue 13.3.3 Merck Preterm Labor Treatment Introduction 13.3.4 Merck Revenue in Preterm Labor Treatment Business (2015-2020) 13.3.5 Merck Recent Development 13.4 Sanofi 13.4.1 Sanofi Company Details 13.4.2 Sanofi Business Overview and Its Total Revenue 13.4.3 Sanofi Preterm Labor Treatment Introduction 13.4.4 Sanofi Revenue in Preterm Labor Treatment Business (2015-2020) 13.4.5 Sanofi Recent Development 13.5 Johnson and Johnson 13.5.1 Johnson and Johnson Company Details 13.5.2 Johnson and Johnson Business Overview and Its Total Revenue 13.5.3 Johnson and Johnson Preterm Labor Treatment Introduction 13.5.4 Johnson and Johnson Revenue in Preterm Labor Treatment Business (2015-2020) 13.5.5 Johnson and Johnson Recent Development 13.6 GSK 13.6.1 GSK Company Details 13.6.2 GSK Business Overview and Its Total Revenue 13.6.3 GSK Preterm Labor Treatment Introduction 13.6.4 GSK Revenue in Preterm Labor Treatment Business (2015-2020) 13.6.5 GSK Recent Development 13.7 AstraZeneca 13.7.1 AstraZeneca Company Details 13.7.2 AstraZeneca Business Overview and Its Total Revenue 13.7.3 AstraZeneca Preterm Labor Treatment Introduction 13.7.4 AstraZeneca Revenue in Preterm Labor Treatment Business (2015-2020) 13.7.5 AstraZeneca Recent Development 13.8 Cipla 13.8.1 Cipla Company Details 13.8.2 Cipla Business Overview and Its Total Revenue 13.8.3 Cipla Preterm Labor Treatment Introduction 13.8.4 Cipla Revenue in Preterm Labor Treatment Business (2015-2020) 13.8.5 Cipla Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details
List of Tables Table 1. Preterm Labor Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Preterm Labor Treatment Revenue Table 3. Ranking of Global Top Preterm Labor Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Preterm Labor Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Tocolytic Drugs Table 6. Key Players of Beta – Mimetic Table 7. Key Players of Calcium Channel Blockers Table 8. Key Players of NSAIDS Table 9. Key Players of Corticosteroids Table 10. Key Players of Magnesium Sulphate Table 11. Key Players of Antibiotics Table 12. Global Preterm Labor Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Preterm Labor Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Preterm Labor Treatment Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Preterm Labor Treatment Market Share by Regions (2015-2020) Table 16. Global Preterm Labor Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Preterm Labor Treatment Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Preterm Labor Treatment Market Growth Strategy Table 22. Main Points Interviewed from Key Preterm Labor Treatment Players Table 23. Global Preterm Labor Treatment Revenue by Players (2015-2020) (Million US$) Table 24. Global Preterm Labor Treatment Market Share by Players (2015-2020) Table 25. Global Top Preterm Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preterm Labor Treatment as of 2019) Table 26. Global Preterm Labor Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Preterm Labor Treatment Product Solution and Service Table 29. Date of Enter into Preterm Labor Treatment Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$) Table 32. Global Preterm Labor Treatment Market Size Share by Type (2015-2020) Table 33. Global Preterm Labor Treatment Revenue Market Share by Type (2021-2026) Table 34. Global Preterm Labor Treatment Market Size Share by Application (2015-2020) Table 35. Global Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$) Table 36. Global Preterm Labor Treatment Market Size Share by Application (2021-2026) Table 37. North America Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$) Table 38. North America Key Players Preterm Labor Treatment Market Share (2019-2020) Table 39. North America Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$) Table 40. North America Preterm Labor Treatment Market Share by Type (2015-2020) Table 41. North America Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$) Table 42. North America Preterm Labor Treatment Market Share by Application (2015-2020) Table 43. Europe Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Preterm Labor Treatment Market Share (2019-2020) Table 45. Europe Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$) Table 46. Europe Preterm Labor Treatment Market Share by Type (2015-2020) Table 47. Europe Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$) Table 48. Europe Preterm Labor Treatment Market Share by Application (2015-2020) Table 49. China Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$) Table 50. China Key Players Preterm Labor Treatment Market Share (2019-2020) Table 51. China Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$) Table 52. China Preterm Labor Treatment Market Share by Type (2015-2020) Table 53. China Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$) Table 54. China Preterm Labor Treatment Market Share by Application (2015-2020) Table 55. Japan Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Preterm Labor Treatment Market Share (2019-2020) Table 57. Japan Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$) Table 58. Japan Preterm Labor Treatment Market Share by Type (2015-2020) Table 59. Japan Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$) Table 60. Japan Preterm Labor Treatment Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Preterm Labor Treatment Market Share (2019-2020) Table 63. Southeast Asia Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Preterm Labor Treatment Market Share by Type (2015-2020) Table 65. Southeast Asia Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Preterm Labor Treatment Market Share by Application (2015-2020) Table 67. India Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$) Table 68. India Key Players Preterm Labor Treatment Market Share (2019-2020) Table 69. India Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$) Table 70. India Preterm Labor Treatment Market Share by Type (2015-2020) Table 71. India Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$) Table 72. India Preterm Labor Treatment Market Share by Application (2015-2020) Table 73. Central & South America Key Players Preterm Labor Treatment Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Preterm Labor Treatment Market Share (2019-2020) Table 75. Central & South America Preterm Labor Treatment Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Preterm Labor Treatment Market Share by Type (2015-2020) Table 77. Central & South America Preterm Labor Treatment Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Preterm Labor Treatment Market Share by Application (2015-2020) Table 79. Pfizer Company Details Table 80. Pfizer Business Overview Table 81. Pfizer Product Table 82. Pfizer Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$) Table 83. Pfizer Recent Development Table 84. Novartis Company Details Table 85. Novartis Business Overview Table 86. Novartis Product Table 87. Novartis Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$) Table 88. Novartis Recent Development Table 89. Merck Company Details Table 90. Merck Business Overview Table 91. Merck Product Table 92. Merck Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$) Table 93. Merck Recent Development Table 94. Sanofi Company Details Table 95. Sanofi Business Overview Table 96. Sanofi Product Table 97. Sanofi Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$) Table 98. Sanofi Recent Development Table 99. Johnson and Johnson Company Details Table 100. Johnson and Johnson Business Overview Table 101. Johnson and Johnson Product Table 102. Johnson and Johnson Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$) Table 103. Johnson and Johnson Recent Development Table 104. GSK Company Details Table 105. GSK Business Overview Table 106. GSK Product Table 107. GSK Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$) Table 108. GSK Recent Development Table 109. AstraZeneca Company Details Table 110. AstraZeneca Business Overview Table 111. AstraZeneca Product Table 112. AstraZeneca Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$) Table 113. AstraZeneca Recent Development Table 114. Cipla Business Overview Table 115. Cipla Product Table 116. Cipla Company Details Table 117. Cipla Revenue in Preterm Labor Treatment Business (2015-2020) (Million US$) Table 118. Cipla Recent Development Table 119. Research Programs/Design for This Report Table 120. Key Data Information from Secondary Sources Table 121. Key Data Information from Primary Sources List of Figures Figure 1. Global Preterm Labor Treatment Market Share by Type: 2020 VS 2026 Figure 2. Tocolytic Drugs Features Figure 3. Beta – Mimetic Features Figure 4. Calcium Channel Blockers Features Figure 5. NSAIDS Features Figure 6. Corticosteroids Features Figure 7. Magnesium Sulphate Features Figure 8. Antibiotics Features Figure 9. Global Preterm Labor Treatment Market Share by Application: 2020 VS 2026 Figure 10. Hospitals Case Studies Figure 11. Pediatric and Neonatal Clinics Case Studies Figure 12. Nursing Homes Case Studies Figure 13. Pharmacy Case Studies Figure 14. Preterm Labor Treatment Report Years Considered Figure 15. Global Preterm Labor Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 16. Global Preterm Labor Treatment Market Share by Regions: 2020 VS 2026 Figure 17. Global Preterm Labor Treatment Market Share by Regions (2021-2026) Figure 18. Porter's Five Forces Analysis Figure 19. Global Preterm Labor Treatment Market Share by Players in 2019 Figure 20. Global Top Preterm Labor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preterm Labor Treatment as of 2019 Figure 21. The Top 10 and 5 Players Market Share by Preterm Labor Treatment Revenue in 2019 Figure 22. North America Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Europe Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 24. China Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Japan Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Southeast Asia Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 27. India Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 28. Central & South America Preterm Labor Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. Pfizer Revenue Growth Rate in Preterm Labor Treatment Business (2015-2020) Figure 31. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Novartis Revenue Growth Rate in Preterm Labor Treatment Business (2015-2020) Figure 33. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Merck Revenue Growth Rate in Preterm Labor Treatment Business (2015-2020) Figure 35. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Sanofi Revenue Growth Rate in Preterm Labor Treatment Business (2015-2020) Figure 37. Johnson and Johnson Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Johnson and Johnson Revenue Growth Rate in Preterm Labor Treatment Business (2015-2020) Figure 39. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. GSK Revenue Growth Rate in Preterm Labor Treatment Business (2015-2020) Figure 41. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. AstraZeneca Revenue Growth Rate in Preterm Labor Treatment Business (2015-2020) Figure 43. Cipla Total Revenue (US$ Million): 2019 Compared with 2018 Figure 44. Cipla Revenue Growth Rate in Preterm Labor Treatment Business (2015-2020) Figure 45. Bottom-up and Top-down Approaches for This Report Figure 46. Data Triangulation Figure 47. Key Executives Interviewed
Pfizer Novartis Merck Sanofi Johnson and Johnson GSK AstraZeneca Cipla
  • PRICE
  • $3900
    $7800

Our Clients